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STUDY OF HIV-1 TRANSMISSION ACROSS HUMAN CERVICAL TISSUE TO 
THE LYMPHOID TISSUE USING AN ORGAN CULTURE MODEL 
 Jackeline Soto-Rivera, M.S 
University of Pittsburgh, 2008
 
The female genital tract is the main route for heterosexual transmission of HIV-1. Studies with 
SIV in macaque model indicate that after crossing the mucosa of cervix and vagina, SIV infected 
cells migrate to draining lymph nodes where the virus expands before it gets disseminated into 
the gut and other organs of the body. We have developed a combined organ culture system 
composed of cervical tissue together with tonsil tissue (surrogate lymphoid tissue for lymph 
node) to study HIV-1 transmission across the mucosal barrier and to evaluate the fate of HIV-1 
and HIV-1 infected cells after crossing cervical mucosa and migrating to regional lymph nodes. 
To study the transmission of virus, a defined amount of pretitered cell-free or cell-associated 
HIV-1BAL or HIV-1IIIB was added to the top of the cervix tissue and incubated at 37°C in a CO2 
incubator. The top well was removed after 3-4 days and tonsil tissue or tonsil mononuclear cells 
in the bottom well were cultured for an additional 12 days. Replication of cell-free and cell-
associated HIV-1BAL and HIV-1IIIB in tonsillar cells after crossing the cervix mucosa was 
confirmed by the presence of HIV-1 p24 in culture supernatant, the detection of HIV-1 DNA by  
real-time PCR, presence of p24 antigen by immunofluorescence assay and presence of HIV-1 
RNA  by simultaneous immunophenotyping and ultrasensitive fluorescence in situ hybridization. 
We have also characterized by immunofluorescence assay HIV-1 infected migratory cells exiting 
from the cervix tissue. CD4+ (T cells), CD11c+ (dendritic cells) and CD68+ (macrophages) cells  
 
iv 
were found to migrate from cervix tissue and were positive for HIV-1. The public health 
relevance of this model is that we may use the combined cervix and tonsil tissue/cell model to 
determine the mechanism of sexual transmission of HIV-1 in women at the cellular and 
molecular level and to evaluate anti-HIV microbicides. 
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 1.0  INTRODUCTION 
1.1 ORIGINS OF HIV-1 
Viral transmission is governed by two universal models: the maintenance of infection in one 
species and the repeated infection by insects into vertebrate hosts (Flint, 2004, p. 523). However, 
viruses occasionally transfer from one species to another, including from animals to humans. 
Sometimes humans become a dead-end host following animal-to-human transmission while at 
other times the virus can further adapt to propagation in humans facilitating human-to-human 
transmission (Webby, 2004). RNA viruses are more frequently able to cross species. RNA-
dependent RNA polymerases have no proofreading activity during replication and thus viral 
replication introduces mutations that create viruses that may become successfully transferred to 
susceptible hosts. Influenza (Kawaoka,  1989) and human immunodeficiency virus (HIV) are 
examples of this phenomenon in which an RNA virus typically found in animals has become a 
prevalent viral infection in humans.  
Through genetic analysis, researchers have demonstrated that HIV-1 emerged from 
SIVcpz of chimpanzees whereas HIV-2 arose from SIVsm of sooty mangabeys (Lemey, 2003; 
Chen, 1995). Scientists believe that HIV-1, the major causative agent of acquired immune 
deficiency syndrome (AIDS), crossed to the human population when humans hunted the 
chimpanzees and were exposed to their infected blood (Hahn, 2000). It is estimated that HIV has 
been present in human populations since the 1930s (Hillis, 2000).  Early evidence of HIV-1 
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 infection has been found in a serum sample obtained in 1959 from a Bantu male in Kinshasa in 
the Democratic Republic of Congo (Sharp, 2002). However, HIV only appeared prevalent during 
the 1980s in the United States and Europe.  
1.2 HIV EPIDEMICS 
HIV-1 has spread to more than 150 countries on six continents (McCutchan, 2006). 
Approximately, 33 million people worldwide are currently infected with HIV, with 2.7 million 
new infections of HIV and 2 million HIV-related deaths estimated to have occurred in 2007 
(UNAIDS/WHO (2008) Global Summary of AIDS Epidemic 2008; December 2007. 
www.unaids.gov).   
The majority of HIV-1 new infections occur through heterosexual contact, even though 
injection drug use, sex between men and mother-to-child transmission make up a significant part 
of transmission groups in some countries (UNAIDS, 2008). The most affected group around the 
world is young women between ages 15-24. Women, among all people living with HIV 
worldwide, have remained at 50% for several years and almost 60% of HIV infection in sub-
Saharan Africa (figure 1) (UNAIDS/WHO (2008), Report on the global AIDS epidemics: Status 
of the Global HIV Epidemics; December 2007 < www.unaids.gov>).  
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Figure 1: Percent of adults (15+) living with HIV who are female, 1990–2007.   
Adapted from publicly available data from UNAIDS and WHO. <www.unaids.org>. Reproduced by 
kind permission of UNAIDS. © 2008 Report on the global AIDS epidemic. 
1.3 HIV LIFECYCLE 
HIV infection begins when the surface protein gp120 of virus particle binds to cellular 
glycoprotein CD4 (Moore, 1993), mainly expressed in CD4+ T cells, monocytes and 
macrophages.  This initial binding facilitates further binding of gp120 to co-receptor molecules, 
the main two being chemokine receptors CCR5 (R5 tropic virus) and CXCR4 (X4 tropic virus) 
(Clapham, 2002). Binding of the co-receptors induces fusion of viral and cellular membranes and 
then the release of the viral core into the cell cytoplasm where the viral RNA genome is reverse 
transcribed into DNA by the viral reverse transcriptase (Hirsch, 1990, 4th ed.; Harrich, 2002.). 
The viral DNA, or pre-integration complex (PIC), is carried to the nucleus by HIV Vpr and other 
viral proteins and integrated into the host cell chromosome by the viral integrase (Stevenson, 
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1990). Proviral transcription takes place when cellular RNA polymerase and various cellular 
factors bind to the viral long terminal repeat promoter which synthesizes genomic full-length 
copies of viral RNA and mRNA encoding viral proteins (El Kharroubi, 1998). During this time, 
Gag, Gag-Pol precursors and Env polyproteins move to the host cellular plasma membrane 
where they meet the viral RNA and start to assemble the virion components (Adamson, 2007; 
Orenstein, 1988). The new virus then buds from the plasma membrane as an immature virion 
(Ono, 2001; Nguyen, 2000). The virion matures and becomes infectious when, shortly after 
budding, the viral protease cleaves the Gag and Gag-Pol polyprotein (Lanman, 2002; Briggs, 
2003).   
 
 
 1.4 NATURAL HISTORY OF HIV-1 INFECTION 
Most people infected with HIV do not rapidly progress to AIDS. HIV is a lentivirus that 
belongs to the Lentivirus genus from the Retroviridae family.  Lenti- means slow and for this 
reason these viruses have long incubation periods, therefore, HIV can take years to cause AIDS. 
It has been estimated that the mean incubation of disease development is 10 years (Muñoz, 
1995; Hendriks, 1993). There are three distinct phases of natural history of HIV infection. First, 
acute infection, occurring between 2 to 6 weeks, described as influenza-like symptoms in 60-
80% of cases. Symptoms typically consist of fever, sore throat, muscle ache and swollen lymph 
nodes (Levy, 2007, 3rd ed.). Second, asymptomatic/chronic infection, which can last for 
approximately 10 years, is characterized by nearly undetectable viral replication in the 
peripheral blood (Pantaleo, 1993). Third, the symptomatic period, classified as AIDS and 
defined with an increase in viral load, a fast decline in CD4+ T cell numbers (Pantaleo, 1993), 
and an onset of opportunistic infections, for example, oral candidiasis by Candida microbes and 
pneumonia by fungus Pneumocystis carinni  (Kasper, 1998).  
The function of the lymph nodes is in setting an immune response to invading pathogens 
ensuing the formation of an adaptive immune response. During the acute phase of infection, 
upon HIV transmission, the virus is disseminated, primarily to the lymphoid tissues (Pantaleo 
1993, Fox, 1991), which are replication sites for HIV-1. The immune system is activated after 
HIV has spread to the lymphatic tissues. Then, there is the stage of chronic activation in which 
viral load is maintained at low levels throughout the chronic phase of infection.  A strong 
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 adaptive immune response to HIV controls viremia by the cytolytic activity of virus-specific 
CD8+ T cells during the asymptomatic phase of infection (Betts, 2006; Kaul, 2000). The 
continuous action of CD8+ T cells and HIV specific neutralizing antibodies (Pantaleo, 1997) 
appears to be responsible of controlling virus levels in peripheral blood where viral loads can 
reach between 106 to 107 copies/ml (Daar, 1991). Therefore, during this period the virus levels 
decline while CD4 T cell counts recover, yet never reach to pre-infection levels. It is also during 
this time that HIV target cells, CCR5+CD4+ effector  memory T cells mainly present at 
mucosal sites, i.e. gut and cervicovaginal tissue, are depleted from mucosal sites  (Grossman, 
2006). The numbers of infected CD4+ T cells that die per day are more than 10-100 million 
(Cavert, 1997), thus, CD4+ T cell level in the blood gradually declines. It is when the level of 
CD4+ T cells drops to approximately 200 cells/ml in blood that the host no longer is capable of 
controlling HIV replication. This happens because CD4+ T cells are essential in the 
development and maintenance of CD8+ T cell and antibody immune responses (Heeney, 2002). 
As CD4+ T cell levels decline, the host is not able to fight infection, the immune system is 
weakened and develop AIDS. Therefore, individuals with AIDS are vulnerable to opportunistic 
infections.  
1.4.1 Role of the lymph node in HIV pathogenesis 
Lymph nodes are the reservoirs and replication sites for HIV. This has been shown in 
asymptomatic individuals that demonstrated to have high viral load in lymphatic tissues with 
roughly no detectable viral replication in their peripheral blood (Pantaleo, 1993).   
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 Lymph nodes are organized in a highly specialized and compartmentalized structure that 
comprise of follicular regions containing B cells and interfollicular regions that contain naïve 
and central memory T cells and antigen presenting cells, particularly dendritic cells. These 
antigen presenting cells carry antigens through the afferent lymphatics and into the T cell 
regions where presentation occurs for initiation of an immune response to the presented antigen 
(Veazey, 2003).  Similarly, intra-epithelial dendritic cells and Langerhans cells in the vaginal 
mucosa are considered targets for HIV transmission through intact mucosal tissue. Langerhans 
cells express CD4, CXCR4 and CCR5 (Weissman, 1997; Zaitseva, 1997), can be infected by 
HIV (Kawamura, 2000) and presumably migrate from the epithelium to the afferent lymphatic 
vessels leading to the genital lymph nodes. The virus is amplified in these lymph nodes, 
spreading among T cells and antigen presenting cells. Lymph nodes in acute HIV infected 
individual are enlarged at this stage of infection (Schacker, 1996; Tindall, 1998). As the disease 
progresses, the tissue architecture breaks down and follicular dendritic cells are destroyed. The 
function of the lymph node is interrupted as it can no longer support strong T cell and B cell 
responses (Collier, 1988; Kroon, 1994), possibly by the infected host’s inability to expand naïve  
and memory T cells during chronic HIV-1 infection (Sieg, 2001). Cell-free and cell-associated 
HIV exits the lymph nodes through the efferent lymphatics to the systemic circulation raising 
the viral load in the blood (Miller, 1992). In general, individuals with advanced HIV infection 
and AIDS have lymph nodes that are small, fibrotic, and profoundly depleted of lymphocyte 
populations (Biberfeld, 1987). At this stage, AIDS is imminent.  
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 1.5 HIV TRANSMISSION 
 Newly acquired HIV-1 infections occur by virus transmission across mucosal surfaces (Hu, 
2004; Belyakov, 2004; Lehner, 2003) with unprotected heterosexual intercourse being the major 
route of transmission. 
1.5.1 Female genital tract cellular structure 
Heterosexual sex accounts for 80% of new infections (Poonia B, 2006). During unprotected 
heterosexual intercourse, the cervix and vagina are the main sites of HIV acquisition (Miller, 
1998, Gupta, 1997). The lower female genital tract consists of the vaginal mucosa, the 
ectocervix and the endocervix (van Herrewege, 2007). The vaginal mucosa and the ectocervix 
comprise of several layers of lined nonkeratinizing stratified squamous epithelium that form a 
natural barrier to block HIV infection. The transformation zone, a multilayered 
squamocolumnar junction, is where the ectocervix transitions to a single layer of mucin-
secreting columnar epithelium called the endocervix (Shattock , 2003).  
1.5.2 Mechanisms of sexual transmission 
Unbreached vaginal and cervical epithelium provides a considerable barrier to HIV-1 infection 
(Greenhead, 2000), so it is unclear how cell-free or cell-associated HIV-1 enters the intact 
mucosa to start an infection through the sexual route (Miller, 1992). In general, establishing an 
infection with HIV-1 through the sexual route is not efficient. The rate of HIV-1 transmission in 
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 a single exposure from an infected male to an uninfected female is 0.3% (Miller, 1994; Lehner, 
2003; Belyakov, 2004). Some factors affecting low transmissibility of HIV-1 in women include 
the menstrual cycle stage, vaginal pH, endocrine hormone levels and contraceptive use being 
menstruation and vaginal pH to mainly affect the vaginal viral load (Benki, 2004; Schwebke, 
2005; Quinn, 2005). Furthermore, HIV-1 virions and infected lymphocytes are inactivated by 
the low pH present in vaginal secretions. Vaginal pH can be raised to 7.0 by presence of semen 
and blood in the vagina either during the menstrual cycle or intercourse. Conversely, 
inflammation and trauma to the vaginal epithelia, including that caused by other sexually 
transmitted diseases, and hormonal contraceptives can increase the risk of HIV transmission and 
allow the immigration of the virus to susceptible cells in the submucosa (Lavreys, 2004; Sagar, 
2004).   
Certain cell surface receptors can influence HIV-1 binding and entry into the mucosal 
epithelium. Association of HIV-1 with dendritic cells through the binding of C-type lectins such 
as dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) 
can either confine the virus in the lumen (Pope, 2003), or become infected and transfer the virus 
to susceptible cells. A recent study demonstrated that gp340, expressed on the cervicovaginal 
epithelium, specifically bind to HIV envelope and can enhance the entry of HIV through the 
epithelium (Stoddard, 2007). Figure 2a illustrates the cell receptors that have been implicated 
for HIV-1 binding and infection. Moreover, several HIV-1 entry mechanisms have been 
described (figure 2b): a) entry of cell-free virus into epithelial cell gaps that is then captured and 
internalized by intraepithelial Langerhans cells; b) fusion of virus into intraepithelial CD4+ T 
cells productively infecting these cells; c) migration of cell-free or cell-associated virus through 
unbreached vaginal epithelium into the mucosal stroma where it can be taken up by lymphatic 
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 or venous vessels and carried to local lymph nodes or the blood circulation, respectively; d) 
transcytosis of cell-free virus through epithelial cells (Hladik, 2008). Regardless of the 
mechanism of HIV transmission, virus successfully crosses the cervicovaginal mucosa and has 
access to underlying susceptible cells.  
 
Figure 2: Pathways of HIV invasion in the mucosa of the vagina and uterine ectocervix.  
A) Different cell receptors relevant for HIV binding and infection.  B) Possible mechanisms for HIV 
entry: a) entry of cell-free virus into epithelial cell gaps; b) fusion of virus into intraepithelial CD4+ 
T cells; c) migration of cell-free or cell-associated virus through unbreached vaginal epithelium into 
the mucosal stroma; d) transcytosis of cell-free virus through epithelial cells. Reprinted by 
permission Macmillan Publishers Ltd. from Hladik and M. Juliana McElrath, 2008. Setting the 
stage: host invasion by HIV.  Nat Rev Immunol 8(6): 447-457. Copyright © 2008 Nature Publishing 
Group. <www.nature.com>.
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 1.5.3 Cellular targets of HIV infection  
To determine the cellular targets that first become infected in the cervicovaginal mucosa, a 
SIV/rhesus macaque model and in situ PCR amplification of HIV-1 DNA was used. In this 
model, SIV-infected cells were detected first in the lamina propria immediately adjacent to the 
vaginal mucosa but not in the epithelium itself.  According to morphology and immunostaining 
techniques, the initial SIV-infected cells appeared to be Langerhans cells present in the lamina 
propria although infected Langerhans cells was not confirmed (Spira, 1996). In comparison, 
Zhang et al. (1999) found by in situ hybridization and immunohistochemical staining of 
macrophages, dendritic cells and T cells, that the largest group of cells to first become 
productively infected following 3 days of SIV intravaginal inoculation on monkeys was CD4+ 
T cells. More importantly, these CD4+ T cells comprised of both activated and resting T cells. 
Hu et al (Hu, 2000) showed that most of the cells that were infected within 60 minutes of 
intravaginal exposure to SIV were intraepithelial dendritic cells that subsequently migrated to 
the draining lymph nodes within 18 hours of vaginal exposure.  
In cervical tissue from chronically HIV-1-infected women, T cells, macrophages and 
Langerhans cells were found to be the cell types infected with HIV-1 (Pomerantz, 1988). There 
are no data to designate the cell types initially infected in the reproductive tract of women. Our 
lab have developed a human cervical tissue-based organ culture in which we have shown that 
the first cells to become infected with HIV-1 within 6-24 hr of viral exposure are activated T 
cells located immediately below the epithelial cells. HIV-1-infected dendritic cells and 
macrophages were detected after 3 days of infection (Greenhead, 2000). Interestingly, a most 
recent study by Hladik et al (Hladik, 2007) showed, by using an organ culture of separated 
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 vaginal epithelium, that HIV-1 enters intra-epithelial CD4+ T cells almost exclusively without 
requiring passage from Langerhans cells. However, it is not clear how the infection is 
transmitted after crossing cervical mucosa to regional lymph nodes.  
1.5.4 Role of viral phenotypes in HIV-1 infection 
The mucosal columnar epithelium of the endocervix contain a vast number of activated CD4+ T 
cells that express high levels of CCR5 (Stahl-Hennig, 1999; Veazey, 2003). Even as three HIV-
1 phenotypes, R5, X4 and dual-tropic (R5X4), have been described for many HIV-1 subtypes 
(Delwart, 1998; Pillai, 2005; Scarlatti, 1993), most of the virus associated with acute infection 
are R5 tropic, despite the route of transmission (Zhu, 1993; van't Wout, 1994). This is seen in 
individuals with a 32 base pair deletion of the CCR5 gene which results in nearly full resistance 
to HIV infection and slow progression to AIDS when compared to individuals with wild type 
CCR5 (Huang, 1996; Liu, 1996). A selective transmission of homogeneous R5 tropic virus is 
seen in acutely infected men during homosexual transmission (Zhu T. N.-J., 1996). However, 
data from Long et al (Long, 2000) indicate that selective transmission of HIV-1 may not occur 
in women. For this reason, the role of viral phenotype in sexual transmission in women needs to 
be elucidated.  
The mechanism of HIV-1 transmission may well depend if the transmitting virus is cell-
free or cell associated as semen contains both cell-free and cell-associated HIV-1 (Vernazza, 
1996; Gupta, 1997). It is suggested that HIV-1 transmission mostly occurs via cell-free virus 
since low levels of HIV-1- infected cells and high levels of cell-free HIV-1 have been detected 
in semen during all stages of disease (Gray, 2001). Data from the SIV/rhesus macaque model 
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 indicates that cell-free SIV is more efficient than cell-associated SIV in vaginal transmission 
(Miller, 1992, 1994). However, it is still unclear which HIV-1 phenotype, if cell-free or cell-
associated, is the most significant in male to female transmission. 
1.6 ORGAN CULTURE TO STUDY TRANSMISSION 
Studies with vaginal epithelial sheets have shown that HIV is taken into the cell’s cytosol and 
endocytic compartments (Hladik, 2007) and that new viruses produced from epithelial sheets 
are able to infect susceptible leukocytes (Bomsel, 1997; Bobardt, 2007). Our laboratory has 
developed an organ culture model using ectocervical tissues to study HIV-1 transmission across 
the female genital tract (Collins, 2000) and has demonstrated viral transmission from cell-free 
and cell-associated HIV-1. Unlike other studies, the cervix tissue in our model includes the 
epithelial layer and the stroma papillae. The stroma side is enriched with dendritic cells which 
virions can infect or be internalized by and then passed on to CD4+ T cells. This model is useful 
to study HIV-1 transmission across the mucosal barrier as it provides the natural tissue 
architecture, including epithelial cells, submucosa, and immune cells such as T cells, 
macrophages and Langerhans cells that allows for the evaluation of transmission of cell-free and 
cell-associated infectious HIV-1. The major infected cell types detected in the submucosa were 
activated CD4+ T cells and the co-receptor usage of virus in infected tissue displayed the 
phenotypic properties of infecting virus (Gupta, 2002). Transmission in our organ culture model 
has proven to be reproducible from tissue to tissue and requires infectious virus. A number of 
investigators have confirmed the utility of cervical and anal tissue based organ culture to study 
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 HIV-1 transmission and evaluate anti-HIV-1 activity of microbicides (Abner, 2005; Collins, 
2000; Greenhead, 2000; Gupta, 2002; Narimatsu, 2005; Patterson, 2002). 
The acquisition of HIV through the sexual route and spread to the lymph nodes has been 
continuously studied in macaques. However, transmission of HIV infection to the regional 
lymph nodes after crossing cervical mucosa in humans is not clear. Because human lymph 
nodes are difficult to assess routinely for studies of HIV infection, we used palatine tonsil 
tissues as a surrogate for lymph node tissues. 
My thesis describes the development of a combined organ culture system with cervical 
tissue and tonsil tissue to mimic migration of virus and infected cells after crossing cervical 
mucosa to regional lymph nodes. The palatine tonsil is a secondary lymphoid organ that is 
routinely used as surrogate for lymph nodes. The external surface of the tonsil consists of 
stratified squamous epithelium, with invaginations known as tonsillar crypts. The crypts are 
lined by reticulated epithelium populated mainly by epithelial cells and leukocytes and has been 
suggested to function on the constant process of antigen sampling in the oral cavity (Nave, 
2001; Perry, 1998).  Well established tonsil organ culture to study HIV infection on lymph 
nodes have been described (Glushakova, 1995, 1999; Zhao, 2004, Southern, 2004). Maher et al 
(Maher, 2005) showed that cell-free HIV can establish infection in tonsil tissue when virus was 
applied directly to the tissue block.  
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 2.0  HYPOTHESIS AND SPECIFIC AIMS 
Rationale 
Very little is known about how virus gets disseminated into the body after crossing 
cervical/vaginal mucosa. The macaque model used by Miller et al. established that the first 4 
days after exposure the virus stays underneath the cervicovaginal epithelium and very little 
virus has been transported to the systemic lymphoid organs. However, 5-6 days later the small 
founder population under the cervicovaginal epithelium amplifies enough to travel to the 
systemic lymphoid organs (Miller, 2005). These results reveal that migration of cell-free virus 
and infected cells to the regional lymph nodes is an important source for systemic dissemination 
of HIV-1. However, it is difficult to study the fate of virus and virus infected cells after crossing 
cervical mucosa in women. Therefore, an in vitro model is required to study the process of viral 
migration to the lymph nodes.  A combined cervical and tonsil tissue/cell model may offer an 
ideal ex vivo system to study the fate of HIV-1 and HIV-1-infected cells after crossing the 
cervical mucosa and migrating into the regional lymph node. 
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 Hypothesis 
The migration of virus and virus infected cells after crossing the cervical mucosa into regional 
lymph node can be studied in an organ culture system employing cervical and tonsil tissue.  
 
Specific Aims 
This hypothesis is addressed by the following two Specific Aims: 
1. Develop a combined cervical and tonsil tissue model to study migration of HIV and 
HIV-infected cells to regional lymph nodes. 
2. Characterize the phenotypes of HIV-infected cervical cells migrating out from cervical 
tissue. 
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 3.0  MATERIALS AND METHODS  
3.1 Sources of tissues 
Ectocervical tissues were obtained from the Tissue Procurement Program at Magee Women’s 
Hospital from HIV-1 negative, premenopausal women aged 50 or below undergoing 
hysterectomy with no history of sexually transmitted diseases.   
Tonsil tissues were obtained from routine tonsillectomy performed at Children’s 
Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA. Tonsil tissues with 
obvious abnormal sections were not considered for the study.   
All tissues were processed in the laboratory within 1-5 hours post surgery.  
Use of tissues for this study has been approved by the IRB of the University of 
Pittsburgh. 
3.2 CD8-depleted peripheral blood mononuclear cells (PBMCs) 
Separation of PBMCs was obtained from HIV-1 seronegative whole blood on lymphocyte 
separation medium gradients. Cells were washed twice with Hanks’ buffered saline solution 
(HBSS) (Gibco BRL), resuspended in complete IL-2 medium (RPMI-1640 supplemented with 
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 10% heat-inactivated fetal bovine serum (FBS), 500 U of IL-2 and 100 μg/ml NormocinTM). 
CD8+ lymphocytes were depleted from PBMCs by attachment to immunomagnetic beads –
negative selection (Dynabeads®CD8; Invitrogen). CD8+ beads were added to a 15 ml conical 
tube, washed twice with cold phosphate-buffered saline (PBS) containing 2% FBS (PBS-
2%FBS) and incubated with PBMCs at a bead-to-target-cell ratio of 1:5 in cold PBS-2%FBS at 
4ºC on a rotating rocking platform for 1h. The immunomagnetic captured cells were then 
separated by placing the tube in a magnetic apparatus for 5 minutes. The unbound cells were 
removed by the removal of supernatant and cultured at a concentration of 1 x 106 cells per ml in 
a T75 flask at 37ºC in a 5% CO2 incubator.  All incubations at 37ºC were performed in a 5% 
CO2 incubator unless otherwise mentioned. 
3.3 Virus stocks 
To prepare cell-free virus stock, CD8-depleted PBMCs at a concentration of 1 x 106/ml in 10% 
RPMI 1640 medium (10% FBS and 100 μg/ml NormocinTM (Amaxa)) were stimulated with 
5μg/ml phytohemagglutinin (PHA) in a T75 flask for 48-72 hours at 37ºC and subsequently 
cultured for one hour in complete RPMI with 5μg/ml polybrene in a T25. Following incubation, 
cells were transferred to a 15 ml conical tube and pelleted by centrifugation for 5 minutes at 500 
x g.  Supernatant was discarded and cell-free HIV-1BAL or HIV-1IIIB virus was added directly to 
10 x 106 pelleted cells at a volume of 1 ml of 50%  tissue culture infectious dose of 106 (106 
TCID50) and incubated for 2 hours at 37ºC. Samples were shaken every 15 minutes during the 2 
hour incubation period. Subsequently, cells were washed twice with 10 ml of 10% RPMI, 
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 resuspended in complete IL-2 medium at a concentration of 1 x 106/ml. Cells were cultured at 
37ºC. Culture supernatants were harvested on day 7 in a 50ml conical tube, centrifuged for 5 
minutes at 500 x g and 1ml aliquots of supernatant were stored at -70ºC. Virus stock was used 
as cell-free virus in tissue/ cell culture experiments. HIV-1BAL strain was used as R5 tropic virus 
and HIV-1IIIB as X4 tropic virus.  
3.4 Acutely infected HIV-1 cells 
Fifty million CD8-depleted PBMCs were incubated in 10% RPMI containing 5μg of polybrene 
per ml for 1 h at 37ºC. Subsequently, cells were centrifuged at 500 x g for 10 minutes, 
resuspended in 1 ml of cell-free HIV-1BAL or HIV-1IIIB and incubated for 1 h at 37ºC. The cells 
were washed twice with HBSS and cultured at 37ºC with complete IL-2 medium for 2 days. 
Following incubation, cells were harvested, washed twice in HBSS and one ml aliquots of 5 x 
106 cells were frozen with 10%DMSO/90%FBS at -70ºC overnight and then transferred to -
140ºC.    
Acutely infected CD8-depleted PBMCs were used as cell-associated virus in tissue and 
cell culture experiments.   
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 3.5 Cell-free HIV-1 titration assay  
CD8-depleted PBMCs that have been treated overnight with PHA were centrifuged at 500 x g 
for 10 minutes and resuspended in 10% RPMI. Cells were treated for 1 h with 10% RPMI 
containing 5μg/ml polybrene. Following incubation, cells were pelleted and resuspended in 10% 
RPMI. Two hundred thousand cells were seeded in a 96-well plate and serial dilutions of 1:5 
thawed cell-free HIV-1BAL or HIV-1IIIB in 10% RPMI media was added to each row containing 
the pre-seeded cells and incubated at 37ºC for 7 days. Subsequently, 1:10 dilutions of culture 
supernatants were harvested and frozen at -70ºC. Thawed aliquots were measured for infectivity 
titer by an HIV p24 ELISA kit (PerkinElmer Life Sciences, Inc., MA, USA) according to the 
manufacturer’s protocol.  
3.6 Titration of cell-associated HIV-1 
Thawed acutely infected cells were cultured in complete IL-2 medium at a concentration of 1 x 
106 in a T25 flask for at least 4 hours.  Following incubation, cells were pelleted and 
resuspended in complete IL-2 medium. 1x106, 5 x 105, 2 x 105, and 1 x 105 cells were seeded in 
a 48-well plate and cultured for 3 days at 37ºC. Culture supernatant was then harvested at 1:5 
dilutions in complete IL-2 medium and frozen for at least 24 h at -70ºC. Cell-associated culture 
supernatants were tested for infectivity titer by an HIV p24 ELISA kit. Cell concentrations with 
the highest p24 levels were used as cell-associated virus, i.e., 2 x 106 cells. 
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 3.7 Organ Culture with combined cervical and tonsil tissue/cells 
Cervical tissues were immersed for 5 minutes in a concentrated antibiotic solution containing 
20,000 U/ml Penicillin/Streptomycin, 120 U/ml Nystatin and 250 μg/ml Fungizone in PBS and 
then rinsed twice with Dulbecco’s Modified Eagle’s Medium (DMEM). The stromal side was 
cut to approximately 2-3mm thick, and a 6.0mm-diameter punch biopsy of cervical tissue was 
placed on the top chamber of a 12-well TranswellTM (3μm membrane pore size) with the 
epithelial layer facing upwards (figure 8). The area surrounding the cervical tissue was sealed 
with 3% agarose (SeaKem Le Agarose).  
Tonsil tissues were soaked in HBSS containing 100μg/ml NormocinTM and 5% FBS for 
5 minutes before cutting into 2-4mm3 pieces. Three pieces of tonsil tissues were placed on a 
collagen support (Surgifoam; Pitt SHS Pharmacy, Pittsburgh, PA) at the gaseous/liquid 
interface in complete IL-2 medium on the bottom chamber of the TranswellTM. To study the 
transmission of virus, 300μl of cell free HIV-1BAL or HIV-1IIIB of 107 TCID50 or, for cell-
associated HIV,  2 x 105 of pre-tittered HIV-1 infected cells, was added to the cervix tissue on 
the top chamber and incubated for 3 days at 37ºC. TranswellsTM were removed on day 3 and 
tonsil tissues remained in culture for 12 additional days. Culture medium was removed and 
replaced with fresh complete IL-2 medium every three days. At least duplicate tissue samples 
from each patient were used. A TranswellTM with agarose only was used as a negative control 
and a TranswellTM  only served as a positive control for virus replication in tonsil. 
To examine the integrity of the cervix organ culture and any leakiness in the system, the 
virus was removed from the top chamber on day 3. The TranswellTM was transferred to a new 
12-well plate containing 1ml of complete IL-2 media. 300μl of 1% filter-sterilized blue dextran 
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 in complete IL-2 media was added to the TranswellsTM containing cervix, the agarose and 
positive control wells and cultured for another 24 hours at 37ºC. The supernatant in the bottom 
well was placed in a plastic cuvette  then measured using a spectrophotometer at a wavelength 
of 620nm. 
Alternatively, tonsil-derived mononuclear cells were used in the bottom well instead of 
intact tonsil tissue for the combined cervix and tonsil cell model. Tonsil cells were isolated by 
mechanical disaggregation of the tissue, pelleted by centrifugation at 500 x g for 5 minutes and 
resuspended in complete IL-2 medium. 4x106 cells were seeded per well in 1ml and used as 
freshly isolated cells. Otherwise, cells were frozen at -70ºC overnight and transferred to -140ºC 
and used as frozen-thawed cells.  
Viral replication was assessed every three days by production of HIV-1 p24 in culture 
supernatant. Several techniques were used to detect HIV-1 in tonsil tissues or cells after the 12 
day incubation period. Tonsil cells were rinsed twice with HBSS, pelleted and stored at -80ºC to 
be analyzed for proviral DNA by TaqMan real-time PCR; tonsil tissues were frozen in optimum 
cutting temperature (OCT) medium on dry ice and cells were placed on slides to be analyzed by 
immunofluorescence; cells were frozen in 10%DMSO/90%FBS and stored at -140ºC for 
simultaneous immunophenotyping and HIV-1 gag-pol RNA detection by flow.   
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 3.8 Measurement of viral replication 
Samples were taken every 3 days to monitor viral replication in tonsil tissue/cells to be analyzed 
by an end-point HIV p24 ELISA assay. Aliquots if 50μl or 250μl diluted in complete IL-2 
medium (1:5 or 1:10 and 1:0, respectively) were taken from culture supernatants of tonsil 
tissue/cells and stored at -70ºC. Once p24 sample collection was obtained fresh complete 
medium was replenished in the culture supernatant. 
3.9 Histology 
Tonsil tissues were fixed in Streck Tissue Fixative, paraffin embedded and cut into 7μm thick 
sections using a VibratomeTM, adhered to positive charged microscope slides (Fisherbrand) and 
deparaffinized through xylenes and graded alcohols. The slides were then stained with 
hematoxylin and eosin and examined by light microscopy to assess tissue architecture and 
necrosis over the culture period. Slides analysis was performed by Dr. Ronal Jaffe at Children’s 
Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA.    
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 3.10 Antibodies 
Mouse Alexa Fluor 647-α-CD4 (RPA-T4), PE-α-CD68 (Y1/82A), PE-α-CD45RO, PE-α-CD68, 
APC-α-CD11c against human antigens were purchased from BD Pharmingen; mouse FITC-α-
CD20 (CAT-13.6E12), PE-α-CD11c (BU15) against human antigens from Invitrogen 
(CaltagTM); and mouse anti human PC5-α-CD4 and FITC-α-p24 (KC57) antibody against HIV-
1 antigen from Beckman Coulter.  
3.11 Immunofluorescence 
Tonsil cells were washed twice in cold HBSS and placed on positive charged microscope slides 
(Fisherbrand) for 1 hour at room temperature to allow the cells to settle. Cells were fixed 15 
minutes with 2% paraformaldehyde (formalin solution, neutral buffered, 10%; Sigma) in PBS 
(PFA/PBS) and surface stained 1 hour with CD4 (1:20) and CD11c (1:20) antibodies. 
Subsequently, samples were washed with PBS, fixed for 10 minutes with 1% PFA/PBS, 
permeabilized 10 minutes with 0.5% Triton X-100 in PBS, blocked 1 hour with 1% BSA in 
PBS and stained 1 hour for detection of intracellular marker with antibody against CD68 (1:5) 
and  viral proteins with monoclonal p24 antibody diluted with PBS.    
Tonsil tissues blocks were fixed on harvest day in 4% PFA/PBS  and incubated at 37°C 
for 5 hours. Following incubation, the solution was changed as follow: 4% PFA/PBS was 
removed; PBS was added and incubated at 4ºC. Day 2, PBS from the previous day was 
removed and fresh PBS was added and incubated at 4ºC. Day 3, PBS was removed and 10% 
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 sucrose in PBS was added. Day 4, removed 10% sucrose/PBS and added 20% sucrose/PBS. 
Tissues were frozen in OCT medium and stored at -80°C. Frozen tissues were cut into 7μm 
thick sections using a cryostat and adhered to positively charged microscope slides. Tissue 
sections on microscope slides were stored at -20ºC when not immediately used. 
To prepare the frozen tissue sections for staining, slides with frozen tissue sections were 
set to room temperature for 5 minutes, post fixed with 1% PFA/PBS, washed twice in PBS, 
permeabilized with 0.5% Triton X-100, blocked 1 hour with 2% BSA/ PBS and stained with 
p24 (1:50) antibody diluted in PBS. Slides were washed three times with PBS after staining. 
Nuclear counterstain Hoechst (Sigma) was used for both cell and tissue samples after surface 
and/or intracellular staining. All incubations were done at room temperature in a dark 
humidified compartment. Slides were mounted with Gel Mount™ Aqueous Mounting 
Medium (Sigma) for the subsequent addition of the coverslip. Samples were documented using 
a magnification of 40x and 60x using a Nikon Eclipse E600 microscope and a CRI Nuance 
spectral analyzer (CRI Inc., Woburn, MA). Emission filters used were 420 long pass (LP) for 
Hoechst, 520 LP for FITC, and 590 LP for Alexa Fluor 647 and PE.   
3.12 Flow Cytometry 
Tonsil cells were washed twice with cold HBSS and surface stained for CD20, CD4, and 
CD11c, and permeabilized with 0.1% Triton X-100 for intracellular staining of CD68 for 1 hour 
at 4°C. After staining, cells were fixed with 2.5% PFA/PBS and collected using a BD Canto 
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 flow cytometer. Cells were gated on the lymphocyte gate. FCS files were analyzed using 
FlowJo version 7.2.5 (Tree Star, Inc.).      
3.13 TaqMan Real Time PCR 
DNA was extracted from frozen cell pellets as per manufacture’s protocol (PUREGENE® DNA 
Purification kit). DNA pellet was resuspended to 20μl of nuclease free water. A 30μl TaqMan® 
PCR was performed by mixing 5μl DNA with TaqMan® Universal PCR Master Mix 
(AppliedBiosystems), 333nM each of forward and reverse primer and 250nM FAM/ MGB 
labeled probe. The specific primers for HIV-1 BAL-F (5’-TGG GTT ATG AAC TCC ATC 
CTG AT-3’) and BAL-R (5’-TGT CAT TGA CAG TCC AGC TGT CT-3’) were designed by 
Dr. Bruce Patterson (Patterson, 2005).  TaqMan probe was BAL-P (5’-FAM-AAT GGA CAG 
TAC AGC CTA TAG TGC TGC CAG AA-TAMRA-3’). ABI Prism 7000 Sequence Detection 
System was used to carry out Real-Time PCR using the following cycling condition: 50 ºC for 2 
min, 95 ºC for 10 min, 50 cycles of 95 ºC for 15 sec and 60 ºC for 1 min. Serial diluted pNL4-3 
plasmid DNA ranging from 1 to 106 copies were applied to each PCR assay for a standard 
curve. No Template Control was included in each assay to guard against cross contamination. 
Each sample was run in triplicate. ABS Prism 7000 SDS Software (Applied Biosystems) was 
used for PCR data analysis and HIV copy number estimation. 
 
27 
 
 3.14 Simultaneous Immunophenotyping and Ultrasensitive fluorescence in situ 
Hybridization 
Tonsil cells were washed twice in HBSS, resuspended with 10% DMSO/90% FBS, and stored 
at -80ºC. Cells were thawed, rinsed, pelleted by centrifugation and stained for cell markers with 
CD4 and CD68. For the detection of HIV-1 mRNA, cells were treated with ViroTect VR in-cell 
HIV-1 detection system (Invirion Diagnostics).  Flow cytometry was performed in a FC500 
flow cytometer (Beckman-Coulter). This procedure was done by Dr. Bruce Patterson, Stanford 
University, Stanford, CA.  
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 4.0  RESULTS 
4.1 AIM 1  
4.1.1 Replication of HIV in tonsil tissue 
Before we set up the combined cervical and tonsil tissue model, we initiated a study to 
standardize the condition of HIV infection in tonsil tissue itself. To assess HIV infectivity in 
tonsil, 3 pieces of tissue cut into 2-4mm3 were placed on a collagen support at the 
gaseous/liquid medium interface. Tonsil tissues were infected by carefully applying 5 μl of 
serial dilutions (TCID50  1:4, 1:16, 1:64; starting TCID50 of 107-108) of cell-free HIV-1BAL 
directly to the tissue surface. The virus inoculums were washed away on day 3 and the tissue 
culture was continued for 12 days with culture medium replaced every 3 days.  
HIV replication was monitored by measuring HIV p24 in culture supernatant.  A dose 
dependent HIV replication was observed by HIV p24 production in culture supernatant (figure 
3). Evidence of viral replication on the 1:64 virus dilutions is important for the subsequent use 
of virus in the combined tissue model, because approximately 5-10% of HIV-1 gets transmitted 
across the female genital mucosal barrier on our organ culture model.  Figure 4 shows 
expression of p24 antigen in tonsil tissues at day 12 post infection as evidenced by HIV-1 p24 
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 specific  immunocytochemical staining in tonsil tissues. These data demonstrate that HIV-1 
replicated in tonsil tissue.   
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Figure 3: Dose-dependent response to HIV-1 infection in tonsil tissue. 
 
 
 
 
 
  
Figure 4: Single label immunofluorescence detection of HIV-1 p24 positive tonsil cells in 
tonsil tissue.  
Green: p24 antigen; Blue: cell nuclear stain. Original magnification x40.  
 
 
 
To evaluate tonsil tissue integrity, tissues were examined at day 0, day 7 and day 12 post 
infection by hematoxylin and eosin staining (figure 5). On day 0, cell nuclei detail was observed 
at a high power. On day 7, approximately two thirds of the cells in uninfected tonsil tissue 
remained viable as compared to cells observed in the lymphoid compartment of infected tonsil 
tissues in which an estimated 10% of the cells remained viable. Most of the nuclei observed 
were pycnotic. Namely, chromatin condensation representative of cellular apoptosis was seen 
by the dark purple stain and smaller nuclei, whereas a larger nuclear size was seen on day 0.  
Tonsil tissues on day 12 post infection had a lymphoid compartment that was largely destroyed 
despite the observed intact tonsillar epithelium and germinal mantle zones. Therefore, tissue 
disintegration could be due to the effect of HIV-1 in the lymph nodes, representative of a 
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 similar situation that exists in vivo in which the lymph node architecture is destroyed due to the 
damaging effects of the immune activation.  
 
 
Figure 5: Hematoxylin and eosin staining of paraffin embedded infected tonsil tissues at day 0, 
7 and 12.   
Inset: an enlarged section showing microanatomical regions. Original magnification: x20, inset 
magnification: x40.  
 
4.1.2  Replication of HIV in tonsil cells 
As an alternate to tonsil tissue, we considered using tonsil cells in our combined model. First, 
we determined the phenotype of cells present in mechanically disaggregated tonsil cell 
suspension by flow cytometry. These cells consist primarily of CD20 (B cells) (Table 1). A 
significant number of CD4+ and CD11c+ (dendritic cells) and, in lesser amount CD68+ 
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 (monocytes) were found in tonsil cells which are target cells for HIV-1 infection. Following 12 
days in culture, tonsil cells still carried good amount of these cell types, even though their 
relative levels changed somewhat during culture and infection. 
 
Table 1: Percentage expression of tonsil cells markers. 
 
  
 
The susceptibility of single-tonsillar cell suspension to HIV infection was then 
examined. The literature has described different isolation methods for tonsil cells, thus, we 
investigated different isolation methods to determine which one most efficiently supports viral 
replication. To evaluate tonsil cell infectivity tonsil cells were isolated by three different 
methods: 1) pressing small pieces of tissue through a 60um sieve with a syringe plunger and 
lymphocyte separation by using Ficoll-hypaque density-gradient centrifugation, 2) sieve 
separation only, and 3) mechanically disaggregation of the tissue, namely, minced tonsil tissue 
cells. No further Ficoll-hypaque density-gradient to separate the lymphocyte population was 
used on method 2 nor 3. We compared freshly isolated and frozen-thawed cells because it 
would be beneficial if we standardize the system to use frozen-thawed cells as they would 
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 pertain to one donor eliminating variability from experiment to experiment. Cells were exposed 
for 2 hours to serially diluted cell free HIV-1BAL and assessed for viral replication by the 
presence of HIV-1 p24 in culture supernatant (figure 6). All three methods, as well as frozen-
thawed cells, were found to support viral replication. However, HIV replication in freshly 
isolated cells was higher when compared to frozen-thawed tonsil cells. Regardless of fresh or 
frozen, mechanically disaggregated tonsil tissue cells support the highest level of HIV 
replication. This may be attributed to a higher cell diversity population present in mechanically 
disaggregated tonsil tissue cells which are susceptible to HIV infection. Included in 
disaggregated tonsil tissue cells are epithelial cells that may contribute to a strong, though non-
specific binding of HIV virions to tonsillar epithelial cells (Maher, 2004). Therefore, 
mechanically disaggregated tonsil tissue cells were used for subsequent experiments. 
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1) 
2) 
3) 
Figure 6: Viral replication of both freshly isolated tonsillar cells and frozen-thawed cells in 
suspension.  
Tonsil cells isolated by: 1) 60 μm sieve and Ficoll-hypaque density-gradient centrifugation; 2) 
60μm sieve without Ficoll-hypaque density-gradient centrifugation; 3) mechanically 
disaggregated tonsil tissue cells without any further separation, namely, minced tonsil tissue 
cells. 
 
 
Intracellular p24 antigen was also detected in these HIV-1 infected tonsil tissue derived 
cells by using an immunofluorescence assay (figure 7).  A qualitative analysis of the cell types 
that were positive to p24 antigen were identified to be CD4+, CD11c+, and CD68+ detected by 
double-staining of cell markers (red) and intracellular p24 (green) as compared to the single 
staining of p24. Viral replication was also confirmed by the detection of proviral DNA in tonsil 
cells as shown in figure 12, panel C and D.  
 
  
 
Figure 7: Expression of HIV-1 p24 in tonsil cell following infection with HIV-1 BAL 
  
4.1.3 Combined cervical tissue and tonsil tissues 
To evaluate HIV-1 transmission after crossing the cervix mucosa and migrating to regional 
lymph nodes, a combined cervix and tonsil tissue-derived organ culture system was used with 
cervical tissue at the top well and tonsil tissue on the bottom well (figure 8). HIV-1BAL or HIV-
1IIIB was added onto the cervical tissue and incubated for 3 days. Following incubation, the top 
well with cervical tissue was removed and tonsil tissues on the bottom well were cultured for an 
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 additional 12 days. Culture media was removed and replaced with fresh complete IL-2 medium 
every 3 days. Virus replication was monitored every 3 days by measuring HIV-1 p24 in the 
culture supernatant. Since very low HIV p24 was detected in culture supernatant from the 
bottom well with cervical tissue in the top well and only media in the bottom well, an increase 
in HIV p24 in bottom well containing tonsil cells of the combined model is considered as an 
indication of viral replication in tonsil tissue/cells.  However, very little sustained replication 
was observed in combined tissue model with tonsil tissue in the bottom well in which very low 
HIV replication after day 6 was observed from the culture supernatant of tonsil tissue (figure 9). 
However, intracellular HIV p24 was detected in tonsil tissue on day 8 after infection by 
immunofluorescence assay (figure 10). Tonsil tissue alone infected with HIV-1 was used as a 
positive control and shows the presence of HIV-1 p24 positive cells.  Even though we see 
intracellular p24 in tonsil tissue in the combined tissue model, these results were not very 
reproducible.   
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Figure 8: Diagram of the TranswellTM utilized combined organ culture model of HIV-1 
transmission across the cervical mucosa into lymphoid tissue.   
A. TranswellTM with cervix tissue surrounded with agarose B. Agarose only – negative control. 
C. Membrane alone – positive control. Tonsil tissue on collagen support on the bottom well. 
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Figure 9:  HIV-1BAL and HIV-1IIIB replication on tonsil tissue after exiting the cervix tissue.  
 
 
 
 
 
 
Figure 10: HIV-1 p24 expression of day 8 tonsil tissue cultured on the bottom well of a 
combined organ culture system.  
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 Therefore, a combined organ culture was established with tonsil cells in the bottom well 
without the use of a collagen support. Cell-free HIV-1BAL or HIV-1IIIB  (TCID50 of 107) was 
used as inoculums to the cervix tissue. Replication in tonsil cells after transmission through 
cervical mucosa was confirmed by measuring of HIV-1 p24 in culture supernatant (Figure 11). 
HIV-1 p24 production in culture supernatant increased after day 6 of infection with both HIV-
1BAL and HIV-1IIIB.  However, there seems to be higher level of replication with HIV-1IIIB as 
compared to HIV-1BAL. Similarly, higher replication of HIV-1IIIB compared to HIV-1BAL was 
observed in tonsil cells alone. Furthermore, analysis of HIV-1 proviral DNA in tonsil cells in 
the bottom well from virus crossing the cervical mucosa (figure 12, A and B) confirmed 
replication of HIV-1 in tonsil cells. Tonsil cells infected with HIV-1IIIB had higher copy levels 
of HIV-1 proviral DNA per nanogram when compared to tonsil cells infected with HIV-1BAL 
supporting p24 production data shown in figure 10. The low levels of HIV DNA present in 
tonsil cells alone (figure 12, C and D) could be due to a higher dose of virus present in tonsil 
cells alone causing cell death at earlier time points, thus, less infected cells containing HIV-1 
DNA on day 12. Conversely, a low dose of virus crosses the cervix mucosa during the three 
days the cervix tissue is in culture with the tonsil cells and is probably less cytopathic than 
tonsil cells alone infected with HIV-1.  HIV-1 replication in tonsil cells was further documented 
in an immunofluorescence assay by the presence of p24 antigen in tonsil cells (figure 13). 
Analysis of cell types that are harboring p24 antigen indicates that CD4+, CD11c+, and CD68+ 
were infected with HIV-1 after transmission from the cervix tissue (figure 13). A flow 
cytometric simultaneous immunophenotyping and ultrasensitive fluorescence in situ 
hybridization assay was performed to determine the tonsil cell types that become infected after 
virus has crossed the cervix mucosa (Figure 15, A). 
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Figure 11: Viral replication from tonsil cells from combined cervix and tonsil cells. 
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Figure 12: Qualitative analysis of integrated HIV-1 DNA. 
 
  
Figure 13: Expression of HIV-1 p24 in tonsil cells after crossing the cervix mucosa.  
 
After 12 days in culture, tonsil cells were stained with antibodies to CD4 and CD45RO for 
activated T cells, CD11c for dendritic cells and CD68 for macrophages. After labeling, 
ultrasensitive fluorescence in situ hybridization was performed and the cells were examined by 
flow cytometry. Non-specific immunoglobins controls were used to adjust the dot plot 
quadrants (data not shown). Cells were gated according to the forward and side characteristics 
of light scatter. In tonsil cells that have been infected with HIV-1 after crossing the cervix 
mucosa, 3.4% of CD45RO+ T cells were detected to express HIV-1 RNA from HIV-1BAL and 
8.9% from HIV-1IIIB when compared to 0.1% cells from the negative (uninfected) control. 
CD11c data is pending. These results indicate that cell-free HIV-1BAL and HIV-1IIIB crosses the 
cervix mucosa and is able to replicate in tonsil cells.  
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 Next, cell-associated HIV-1BAL and HIV-1IIIB were evaluated for transmission across the 
cervix tissue since semen contains both cell-free and/or cell-associated HIV-1. Therefore, 
transmission of cell-associated HIV-1 could also be important in HIV-1 transmission in the 
female genital tract. HIV-1BAL or HIV-1IIIB infected CD8 depleted PBMCs (TCID50 of 4x103) 
was added onto the cervix tissue as described for cell-free virus. Figure 14 shows replication of 
both cell-associated HIV-1BAL and HIV-1IIIB  in tonsil cells, although, higher levels of HIV-1 
p24 was obtained from HIV-1IIIB. Simultaneous immunophenotyping and in situ hybridization 
was performed (figure 15, B). Approximately 3.0% of CD45RO+ T cells expressed HIV-1 RNA 
on HIV-1BAL and 10.0% on HIV-1IIIB, whereas, CD68+ did not express HIV-1 RNA when 
compared to the negative control. CD11c data is also pending for the cell-associated in situ 
hybridization. 
 
Figure 14: HIV-p24 in culture supernatant from combined cervix and tonsil cells from cell-
associated virus. 
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A. 
B.  
 
Figure 15: Dot plots representing the phenotype of productively infected cells analyzed by 
simultaneous immunophenotyping and ultrasensitive fluorescence in situ hybridization.    
A) Cell-free HIV-1,  B) cell-associated virus in tonsil cells after crossing the cervix mucosa.  
 
 4.2 AIM 2 
4.2.1 Characterization HIV-infected cervical cells after migrating from    
cervix  tissue  
To characterize HIV-1 infected migratory cervical cells after exiting from the cervix tissue a 
cervical tissue derived organ culture (figure 9) was used without tonsil cells on the bottom well.   
A TranswellTM with a 12μm pore size membrane was used to allow cells to migrate out from the 
cervical tissue to the bottom well containing complete IL-2 medium. The cervical tissue was not 
sealed with agarose to allow the passage of cells to the bottom well since agarose constricts the 
movement of cells from cervix tissue to the bottom. Five microliters of HIV-1BAL (TCID50 of 
107) or control medium was carefully added directly to the top of the cervix tissue and incubated 
for 3 days at 37ºC. Migrating cells were harvested from the bottom well on day 3, washed twice 
with HBSS, placed on a positive charged microscope slide and stained with antibodies against 
intracellular p24, and cell markers CD4 (T cells), CD11c (dendritic cells), and CD68 
(macrophages). These cells were chosen because they are the immune cell types that have been 
shown to be infected by HIV-1.  Cells were analyzed by fluorescent microscopy (figure 16). An 
immunofluorescence assay with double staining of intracellular  HIV-1 p24 and cell markers 
indicated that CD4+, CD11c+ and CD68+ were positive for HIV-1BAL.  
45 
 
  
Figure 16: Migratory cells after exiting from cervix tissue. 
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 5.0  DISCUSSION 
This thesis describes a combined cervical tissue derived-organ culture and tonsil derived 
lymphoid cells to study the migration of virus and infected cells after crossing cervical mucosa 
to regional lymph nodes. Previously, our laboratory has developed a cervical tissue derived 
organ culture to study HIV-1 transmission in humans. The benefit of this model is that it 
includes all of the natural architecture of the in vivo conditions, that is, the cervix tissue contains 
stratified squamous epithelium, the submucosa, and immune cells. It was determined that the 
cervix tissue preserved its structural integrity without indications of necrosis after 1 week of 
cultivation and that transmission required infectious HIV-1.  
The combined human cervical and tonsil tissue is an extension of the cervical tissue 
model to investigate HIV-1 transmission from the female genital tract to the regional lymph 
nodes. Our combined tissue system does not have afferent lymphatics to transport infected cells 
exiting from cervix to the regional lymph nodes that are present in vivo. However, the proximity 
of the cervical tissue with tonsil cells in our combined tissue model can serve as the afferent 
lymphatics in vitro. In the present study we provided evidence that infectious HIV-1 virus 
crosses the cervix mucosa and replicates in tonsil tissue/mononuclear cells, although replication 
in tonsil tissue is not robust. Part of the reason of low level of replication in tonsil tissue may be 
because tonsil tissue pieces were not placed at the gaseous/liquid interface medium as done 
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 when assessing infectivity of tonsil tissue alone (section 4.1.1.). The space between the 
TranswellTM membrane and the bottom of the well is approximately 1mm, whereas tonsil tissue 
pieces were approximately 3mm3. O-rings were placed on the plate to elevate the TranswellTM 
to extend the space between the TranswellTM and the bottom well. Enough medium was added 
to the bottom chamber to keep the basolateral surface of the cervix tissue on the TranswellTM 
moist. Even under these conditions, tonsil tissue integrity was not maintained for 12 days in 
culture. Hematoxylin and eosin staining of uninfected and infected tonsil tissue showed that the 
tissue compartments were to some extent maintained up to day 7, although infected tissues 
showed more disintegration compared to uninfected. A much more dramatic loss of tissue 
integrity was observed in the tissue lymphoid compartments of HIV-1BAL infected tonsil tissue 
on day 12 compared to uninfected tissue. This data confirms the comparable characteristics to 
those seen in acutely HIV-1 infected individuals. The lymph node germinal center, rich in B 
cells, T cells and dendritic cells, is destroyed (figure 5), possibly by a strong immune response 
that releases proinflammatory cytokines and chemokines to fight HIV-1 infection.     
We have shown viral infected cells in tonsil tissue from the combined organ culture 
model by immunofluorescence assay, but were not able to detect viral replication from HIV-1 
p24 in culture supernatant (figure 9). The low levels of p24 detected from the culture 
supernatant could be due to focal infection in the tonsil tissue (Miller, 2005), thus, the 
production of HIV-1 p24 may not be enough to be detected by ELISA.   
While standardizing the combined organ culture model we used tonsil cells as a 
complimentary system instead of tonsil tissue. Use of tonsil-isolated cells is beneficial because 
they can be frozen and used in many experiments, eliminating variability from experiment to 
experiment. However, tonsil-isolated cells do not mimic the in vivo situation like intact tonsil 
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 tissue does. Other investigators have used tonsillar cells as a model to study HIV-1 infection in 
the oral cavity (Maher, 2004; Maher, 2005). We used three methods of tonsil cell isolation, i.e., 
lightly pressing tissue through a 60 μm mesh followed by Ficoll-hypaque density gradient 
centrifugation, lightly pressing tissue through a 60 μm mesh gradient without Ficoll gradient 
centrifugation, and cells obtained directly from minced tonsil tissue. While tonsil cells isolated 
by all three methods supported HIV-1 replication, minced tonsil tissue cells supported the 
highest level of replication. This may be due to the presence of other non-lymphoid cells, for 
instance, epithelial cells in minced tonsil tissue cells that may contribute to strong non-specific 
binding of HIV virions. Virions may not necessarily infect these cells but may remain active 
during longer periods of times in endocytic compartment of cells. Moreover, although both 
fresh and frozen-thawed cells supported HIV-1 replication, higher level of HIV-1 replication 
was noted with freshly isolated cells. Flow cytometric analysis of minced tonsil tissue tonsil 
cells showed that they contain appreciable levels of CD4+, CD11c+ and CD68+ cells that are 
known to be the target cells for HIV-1 infection. Tonsil cells on day 1 of cultivation showed that 
the majority of tonsil cells were CD20 (B cells) (86.7%), and that a substantial quantity of cells 
were CD4+ cells (26.6%) and CD11c+ (27.7%). Very low levels of CD68+ cells was present in 
tonsil cell population on day 1. The number of CD20+ and CD11c+ uninfected cells decreases 
at day 12 (5.4% and 2.3%, respectively) possibly due to the absence of antigen (HIV-1) or 
cytokines present in the medium, whereas, CD4+ cells increases to 87.2% as a result of IL-2 
present in the culture medium. The levels of CD20+ and CD11c+ on day 12 post infection are 
higher (11.6% and 16.3%, respectively) as compared to uninfected cells on day 12, most likely 
due to the presence of HIV antigens in the culture medium providing a sub-optimal stimulation 
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 to cells. Moreover, tonsil cell population on HIV-1BAL infected cells is considered to carry a 
good proportion of CD4+ (58.1%) and CD11+ (16.3%) cells following 12 days of cultivation.   
Results from the combined cervical and tonsil cells demonstrated that viral replication is 
comparable to data seen in vivo from monkeys that have received intravaginal inoculation of 
SIV (Miller, 1994). For example, in the macaque model, the virus is replicating on cervical 
tissue before exiting to the lymphatic tissues the first 3-6 days (Miller, 2005; Collins, 2000), 
whereas, in our combined cervix-tissue model virus particles measured by HIV-1 p24 in culture 
supernatant were very low the first 6 days of infection. HIV-1 p24 in culture supernatant was 
always higher after days 6-12.   
The tonsil cell types that become infected after transmission from cervical tissue were 
CD4+, CD11c+, and CD68+ as detected by immunofluorescence. More specifically, 
simultaneous immunophenotyping and ultrasensitive fluorescence in situ hybridization assay 
showed that 3.4% and 8.9% of CD4+ T cells expressed HIV-1 RNA on HIV-1BAL and HIV-
1IIIB, respectively. CD11+ results are pending.  
Transmission of cell-associated virus was also examined since semen contains both free 
infectious HIV-1 and HIV-1 infected cells. Therefore, transmission through the cervix mucosa 
could occur by both cell-free and cell-associated HIV-1. We have shown viral replication in 
tonsil cells of cell-associated HIV-1BAL and HIV-1IIIB. HIV-1 p24 levels in culture supernatant 
were approximately 100-fold lower than cell-free HIV-1BAL and HIV-1IIIB. Therefore, cell-
associated HIV-1 was transmitted less efficiently than cell-free HIV-1. However, similar 
number of CD4+ T cells (2.8% and 10.3% of CD4+ T cells from HIV-1BAL and HIV-1IIIB, 
respectively) was detected to express HIV-1 RNA when compared in situ data of cell-free HIV-
1 after crossing the cervix mucosa. These results are comparable to data from the rhesus 
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 macaque in which cell-free virus was better transmitted than cell-associated SIV (Sodora, 
1998).  HIV-1BAL is most effciecntly transmitted across the cervix mucosa (Collins, 2000), 
however, tthese data show that HIV-1IIIB is more efficient at producing virus in tonsil cells than 
HIV-1BAL after crossing the cervix tissue. The preference for HIV-1IIIB in tonsil cells could be 
explained because tonsil cells express higher levels of CXCR4 coreceptor, thus, higher 
susceptibility to HIV-1IIIB  (Grivel, 1999).  
Identification of infected migratory cells was performed by a qualitative 
immunofluorescence assay which showed that migrating cells have the CD4, CD11c, and CD68 
receptors and all of these cells carried HIV. A study by Hu et al (Hu, 2004)  demonstrated by 
flow cytometry and immunfluorescence assay that the major  cells migrating out of the cervix 
tissue were CD3+HLA-DR- and CD3- HLA-DR +, and that 90% of HLA-DR+ cells 
disseminated HIV-1. We were not able to study relative proportion of the principle cell types to 
be involved in HIV-1 transmission from cervix to the regional lymph nodes. However, future 
studies will use simultaneous in situ hybridization for HIV-1 gag/pol RNA and cellular 
immunophenotyping to quantify the major migratory cells from cervix tissue.  
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 6.0  FUTURE DIRECTIONS 
Future studies using the combined cervical and tonsil cell model will utilize the simultaneous 
immunophenotyping and ultrasensitive fluorescence in situ hybridization assay to determine if 
CD45RO (activated T cells), CD68 (macrophages), and CD11c (dendritic cells) express HIV-1 
RNA, since we have only included data of CD4+ and CD68+ cells. Both cell-free and cell 
associated HIV-1BAL and HIV-1IIIB will be evaluated to determine coreceptor use of these HIV-1 
RNA positive cells by staining for CCR5 and CXCR4.  
To further characterize the HIV-1-infected migratory cells from cervical tissue, an EGFP 
reporter HIV-1 may be added to the cervical tissue in the combined cervix tissue-tonsil cell 
system. The migratory cells can be analyzed by both immunofluorescence assay and flow 
cytometric simultaneous immunophenotyping and ultrasensitive fluorescence in situ 
hybridization. The relative proportion of HIV-1 infected cells and their specific phenotype, 
determined by either technique, will indicate the major cells that may be involved of viral 
transmission and infection from cervix to the regional lymph nodes. 
Proinflammatory cytokines stimulate HIV-1 replication by activating NF-κB, a cellular 
factor that activates HIV-1 transcription (Pantaleo, 1993). In contrast, chemokines can affect 
HIV-1 expression and transmission in a positive or negative manner.  For example, chemokines 
such as MIP1-α, MIP1-β and RANTES can block HIV-1 infection by obstructing attachment of 
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 the viral envelope protein to the viral co-receptor  (Deng, 1996) while some chemokines, such 
as CCL21, CCL19 and RANTES, affect the migration of infected DC to draining lymph node. 
Thus, the organ culture model could be suitably used to study the effect of cytokines and 
chemokines on viral replication in tonsil tissue/cells once the virus crosses the cervical mucosa. 
The migration of leukocytes from cervical tissue may be tested on the effect that chemokines 
(MIP-1α, CCL21, CCL19, and RANTES) and cytokines (IL-4, IL1-β, TNFα, IL-6 and IL-8) 
have on viral replication in tonsil tissue. Other cytokines (IL-2, IL-7, IL-8, IL-10, IL-12p70, 
IFNγ) could also be tested to assess their involvement in migration of leukocytes from cervical 
tissues.  
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 7.0  PUBLIC HEALTH SIGNIFICANCE 
The study of HIV-1 transmission in humans is challenging because there is no appropriate in 
vitro model to study HIV-1 transmission across the cervicovaginal mucosa to its lymphatic 
distribution. Therefore, a combined cervical and tonsil (surrogate for lymph node) tissue-
derived organ culture model will be used to study the mechanisms of viral transmission in the 
female genital tract. Moreover, it will be useful to examine the migration of virus and virus-
infected cells to and replication in the regional lymph node after crossing the cervical mucosa. 
The benefits of this model are that it uses primary, intact tissues rather than a monolayer of 
cells, either primary or transformed, which provides the natural tissue architecture with 
epithelial cells, submucosa, and immune cells, such as T cells, macrophages and Langerhans 
cells, thus mimicking the in vivo situation. 
Another important utility of the combined cervix tissue and tonsil tissue/cells model is 
its use for screening candidate topical microbicides. Microbicides are gels and creams that can 
kill or neutralize the virus when applied to the vagina. Therefore, microbicides may block the 
entry of HIV across the mucosal barrier to prevent HIV infection.  
This model can also be used to determine the role of host factors such as semen, vaginal 
fluid, cytokines and chemokines produced by sexually transmitted infection-related 
microorganisms on such migration. Furthermore, the model can be used to determine the role of 
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 virologic factors, for example, the dependency of HIV-1 transmission on virus phenotypes and 
subtypes. 
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